ClinConnect ClinConnect Logo
Search / Trial NCT06862154

Comparison of the Efficiency of Femur Nerve Block and Intravenous Analgesia Treatment in Hip Fracture Patients

Launched by MARMARA UNIVERSITY · Mar 1, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Ultrasound Guided Analgesia Pain Control

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called femoral nerve block (FNB) compared to traditional intravenous pain relief for patients with hip fractures. Hip fractures are serious injuries, especially for older adults, and managing pain effectively before surgery can help improve recovery and overall satisfaction. The trial will look at how well the FNB reduces pain and the need for stronger pain medications (like opioids) in patients with specific types of hip fractures.

To be eligible for the trial, participants must be at least 18 years old and have a confirmed hip fracture. They should be able to give consent or have someone help them with it. However, certain conditions, such as severe bleeding issues or allergies to pain medications, may exclude someone from participating. If you join the study, you can expect to receive either the femoral nerve block or the intravenous pain relief before your surgery, and researchers will monitor your pain levels and medication needs over time. This study aims to find better ways to manage pain for hip fracture patients, which could lead to better outcomes in recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18 years
  • Radiologically confirmed proximal femur fracture (femoral neck or intertrochanteric fracture)
  • Ability to provide informed consent or have a legal representative provide consent
  • Exclusion Criteria:
  • Hemodynamic instability (SBP \<90 mmHg, HR \>120 bpm)
  • Severe trauma requiring immediate surgical intervention (e.g., multiple trauma, head injury)
  • Bleeding disorders or anticoagulation therapy (INR ≥2.5, platelet count \<50,000/mm³)
  • Known allergy to local anesthetics (bupivacaine) or opioids (fentanyl)
  • Pregnancy
  • Prior administration of local anesthetic blocks or systemic opioids before arrival
  • Periprosthetic fractures or previous surgery on the affected hip

About Marmara University

Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.

Locations

İstanbul, Pendik, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported